Contraception
Volume 83, Issue 2 , Pages 99-101 , February 2011

IUD use in HIV-positive women

  • Sheila M. Quinn

      Affiliations

    • Philadelphia College of Osteopathic Medicine, Philadelphia, PA 19131, USA
    • ,
  • Courtney M. Schreiber

      Affiliations

    • Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 215 615 6531; fax: +1 215 880 9234.

Received 26 April 2010 ,Accepted 12 May 2010.

References 

  1. Sinei SK, Morrison CS, Sekadde-Kigondu C, Allen M, Kokonya D. Complication of use of intrauterine devices among HIV-1-infected women. Lancet. 1998;351:1238–1241
  2. Morrison CS, Sekadde-Kigondu C, Sinei SK, Weiner DH, Kwok C, Kokonya D. Is the intrauterine device appropriate contraception for HIV-1-infected women?. BJOG. 2001;108:784–790
  3. Heikenheimo O, Lehtovirta P, Suni J, Paavonen J. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women—effects on bleeding patterns, ovarian function and genital shedding of HIV. Hum Reprod. 2006;21:2857–2861
  4. Mostad S, Overbaugh J, DeVange D, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet. 1997;350:922–927
  5. UNAIDS calls for virtual elimination of mother-to-child transmission of HIV by 2015. Geneva: UNAIDS Joint United Nations Programme on HIV/AIDS; 2009;
  6. World Health Organization Scientific Working Group on Improving Access to Quality care in Family Planning. Medical eligibility criteria for initiating and continuing use of contraceptive methods. Geneva: World Health Organization; 1996;
  7. Stringer EM, Kaseba C, Levy J, et al. A randomized trial of contraceptive device vs. hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007;197:144.e1–144.e8
  8. Curtis KM, Nanda K, Kapp N. Safety of intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS. 2009;23:S55–S67
  9. Richardson B, Morrison C, Sekadde-Kigondu C, et al. Effect of intrauterine device use on cervical shedding of HIV-1 DNA. AIDS. 1999;13:2091–2097
  10. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ. 1992;304:809–813
  11. World Health Organization Department of Reproductive Health . Medical eligibility criteria for contraception use. 1st ed. Geneva: WHO; 2009;
  12. Cooling H. Successful use of levonorgestrel intrauterine system in a HIV-positive woman. Br J Fam Plann. 1999;25:25–26

PII: S0010-7824(10)00328-8

doi: 10.1016/j.contraception.2010.05.011

Contraception
Volume 83, Issue 2 , Pages 99-101 , February 2011

Article Tools